The role of indoleamine 2, 3-dioxygenase in graft-versus-host disease after human allogeneic hematop

来源 :中华医学会血液学分会第九次全国造血干细胞移植学术会议 | 被引量 : 0次 | 上传用户:delphi_quaker
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的 IDO activity may represent a potential biomarker for the diagnosis and evaluation of graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (allo-HSCT).We conducted this review to emphasize the role of IDO in GVHD after-allo-HSCT.
其他文献
目的 在完整家系中研究不同KIR单体型对单倍体造血干细胞移植(HSCT)预后的影响.方法 156个完整家系包括父母和子女共计468个样本,采用SSP方法进行17种已知KIR基因分型.其中92例患者接受了亲缘单倍体HSCT,包括AML/MDS31例,ALL/NHL45例,CML4例,其他血液病12例.
会议
目的 Introduction: Mesenchymal stem cells (MSCs) contribute to the engraftment of transplanted hemato-poietic stem cells (HSCs).
会议
目的 Background and Objective: Cyclosporine A (CsA) has been used as immunosuppressive therapy after allogeneic hematopoietic stem cell transplantation (HSCT) for about 30 years.
会议
目的 Objectives: To compare the effects of the use of alloSCT from a matched sibling donor which includes single alloSCT, non-myeloablative alloSCT and prior ASCT followed by non-myeloablative alloSCT f
会议
目的 This review discusses recent insights into the role, mechanism, clinical applications, differences and the fundamental interactions of G-CSF and AMD3100 in stem cell mobilisation and chemotherapy f
会议
目的 The detection of fetal liver tyrosine kinase 3 (FLT3) internal tandem duplications (ITDs) has been used as a powerful adverse prognostic indicator for acute myeloid leukemia (AML) in any age group.
会议
目的 To perform a meta-analysis of all studies comparing Antithymocyte globulin (ATG) and alemtuzumab or graft-versus-host disease (GVHD) prophylaxis in allogeneic haematopoietic stem cell transplantati
会议
目的 Chemotherapy can increase treatment-related mortality associated with future hematopoietic stem cell transplantation (HSCT) for patients with relapsed/refractory acute myeloid leukemia (AML) There
会议
目的 To explore the role of reduced-intensity conditioning therapy for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia and Myelodysplastic syndrome.
会议
目的 Peripheral-blood (PB) and bone marrow (BM) are both widely used in hematopoietic stem cell transplantation (HSCT).
会议